LaRocca John has filed 5 insider transactions across 1 company since January 2025.
Most recent transaction: a disposition of 21500 shares of Y-mAbs Therapeutics, Inc. ($YMAB) on September 16, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | LaRocca John | SVP, General Counsel & Secry | D | Common Stock | 21500 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.05% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | LaRocca John | SVP, General Counsel & Secry | D | Employee Stock Option (right to buy) | 142600 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.31% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | LaRocca John | SVP, General Counsel & Secry | D | Employee Stock Option (right to buy) | 42900 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.09% |
| Jan. 17, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | LaRocca John | SVP, General Counsel & Secry | A | Common Stock | 21500 | $0.00 | 21,500.0000 | 44,328,962 | 9999.99% | 0.05% |
| Jan. 17, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | LaRocca John | SVP, General Counsel & Secry | A | Employee Stock Option (right to buy) | 42900 | $0.00 | 42,900.0000 | 44,328,962 | 9999.99% | 0.10% |